Article metrics
PDF
Other content recommended for you
- Protocol of a single group prospective observational study on the diagnostic value of 3T susceptibility weighted MRI of nigrosome-1 in patients with parkinsonian symptoms: the N3iPD study (nigrosomal iron imaging in Parkinson’s disease)
- Ursodeoxycholic acid as a novel disease-modifying treatment for Parkinson’s disease: protocol for a two-centre, randomised, double-blind, placebo-controlled trial, The 'UP' study
- Clinical-genetic model predicts incident impulse control disorders in Parkinson's disease
- Incident impulse control disorder symptoms and dopamine transporter imaging in Parkinson disease
- Neuroendocrine abnormalities in Parkinson's disease
- Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies
- Apathy in Parkinson’s disease
- Neuropsychiatry of the basal ganglia
- Outcomes from stereotactic surgery for essential tremor
- The effects of a mindfulness-based lifestyle programme for adults with Parkinson’s disease: protocol for a mixed methods, randomised two-group control study